BioCentury | Sep 17, 2007
Company News

Medisyn, Mount Sinai School of Medicine deal

...data for one or more lead candidates is expected by the end of the year. Medisyn Technologies Inc....
BioCentury | Nov 6, 2006
Company News

Medisyn, Morwell Diagnostics GmbH deal

...Morwell's MD Biosciences service division and Medisyn partnered to discover and develop small molecules for inflammatory...
...and airway inflammation, multiple sclerosis (MS), pain and Parkinson's disease (PD). Under the five-year deal, Medisyn...
...action using MD Biosciences' Senerga Mode of Action platform and ImmuneProfiler technologies. MD Biosciences and Medisyn...
BioCentury | Mar 20, 2006
Company News

Medisyn board of directors update

Medisyn Technologies Inc. , Minneapolis, Minn. Business: Computational chemistry/biology, Chemistry, Cancer Appointed: Mark Kroll, retired SVP and CTO at St. Jude Medical Inc.'s cardiac rhythm management division WIR Staff cancer...
BioCentury | Mar 20, 2006
Company News

Medisyn scientific advisory board update

Medisyn Technologies Inc. , Minnetonka, Minn. Business: Computational chemistry/biology, Chemistry, Cancer Appointed: Thomas Parr, CSO at Targenta Therapeutics Inc.; and James Brewer, director of clinical affairs at Zoll Medical Corp. WIR Staff...
BioCentury | Oct 3, 2005
Company News

Prolexys Pharma management update

...formerly VP of corporate affairs at NPS Pharmaceuticals Inc.; he replaces Thomas Ingolia, who joined Medisyn Technologies Inc....
BioCentury | Sep 12, 2005
Company News

Eidogen-Sertanty, Medisyn deal

...structure-activity relationships and chemical synthesis data on protein kinases. Eidogen-Sertanty Inc. , San Diego, Calif. Medisyn Technologies Inc....
BioCentury | Sep 5, 2005
Company News

Medisyn management update

Medisyn Technologies Inc. , Minnetonka, Minn. Business: Computational chemistry/biology Hired: Thomas Ingolia as CEO and a director, formerly CEO of Prolexys Pharmaceuticals Inc. WIR Staff...
BioCentury | Jun 17, 2002
Company News

Medisyn management update

Medisyn Technologies Inc. , Minnetonka, Minn. Business: Computational chemistry/biology Hired: Gerald Mattys as CEO and a director, formerly president and CEO of Timm Medical Technologies Inc. WIR Staff...
BioCentury | Mar 1, 1993
Company News

Medicis deal

...Pharmaceutical Corp. (MDRXA) Medicis Pharmaceutical Corp. (MDRXA) has acquired a 75 percent interest in Genetic MediSyn...
...million, based on Friday's closing price of $1.188 a share. MDRXA said it believes Genetic MediSyn...
Items per page:
1 - 9 of 9
BioCentury | Sep 17, 2007
Company News

Medisyn, Mount Sinai School of Medicine deal

...data for one or more lead candidates is expected by the end of the year. Medisyn Technologies Inc....
BioCentury | Nov 6, 2006
Company News

Medisyn, Morwell Diagnostics GmbH deal

...Morwell's MD Biosciences service division and Medisyn partnered to discover and develop small molecules for inflammatory...
...and airway inflammation, multiple sclerosis (MS), pain and Parkinson's disease (PD). Under the five-year deal, Medisyn...
...action using MD Biosciences' Senerga Mode of Action platform and ImmuneProfiler technologies. MD Biosciences and Medisyn...
BioCentury | Mar 20, 2006
Company News

Medisyn board of directors update

Medisyn Technologies Inc. , Minneapolis, Minn. Business: Computational chemistry/biology, Chemistry, Cancer Appointed: Mark Kroll, retired SVP and CTO at St. Jude Medical Inc.'s cardiac rhythm management division WIR Staff cancer...
BioCentury | Mar 20, 2006
Company News

Medisyn scientific advisory board update

Medisyn Technologies Inc. , Minnetonka, Minn. Business: Computational chemistry/biology, Chemistry, Cancer Appointed: Thomas Parr, CSO at Targenta Therapeutics Inc.; and James Brewer, director of clinical affairs at Zoll Medical Corp. WIR Staff...
BioCentury | Oct 3, 2005
Company News

Prolexys Pharma management update

...formerly VP of corporate affairs at NPS Pharmaceuticals Inc.; he replaces Thomas Ingolia, who joined Medisyn Technologies Inc....
BioCentury | Sep 12, 2005
Company News

Eidogen-Sertanty, Medisyn deal

...structure-activity relationships and chemical synthesis data on protein kinases. Eidogen-Sertanty Inc. , San Diego, Calif. Medisyn Technologies Inc....
BioCentury | Sep 5, 2005
Company News

Medisyn management update

Medisyn Technologies Inc. , Minnetonka, Minn. Business: Computational chemistry/biology Hired: Thomas Ingolia as CEO and a director, formerly CEO of Prolexys Pharmaceuticals Inc. WIR Staff...
BioCentury | Jun 17, 2002
Company News

Medisyn management update

Medisyn Technologies Inc. , Minnetonka, Minn. Business: Computational chemistry/biology Hired: Gerald Mattys as CEO and a director, formerly president and CEO of Timm Medical Technologies Inc. WIR Staff...
BioCentury | Mar 1, 1993
Company News

Medicis deal

...Pharmaceutical Corp. (MDRXA) Medicis Pharmaceutical Corp. (MDRXA) has acquired a 75 percent interest in Genetic MediSyn...
...million, based on Friday's closing price of $1.188 a share. MDRXA said it believes Genetic MediSyn...
Items per page:
1 - 9 of 9